Insider Buying: Samraat Raha Acquires 40,000 Shares of Myriad Ge

robot
Abstract generation in progress

Samraat Raha, President and CEO of Myriad Genetics Inc (MYGN), recently purchased 40,000 shares of the company, increasing his total holdings to 493,104 shares. This transaction is part of a trend of insider buying within the company, with no insider sales reported in the past year. Despite the insider confidence, Myriad Genetics shares were trading at $5, significantly below its GF Value of $17.74, leading GuruFocus to flag it as a “Possible Value Trap, Think Twice.”

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin